Episode Description

Join Sarah Anderson, Therapeutic Strategy Director - Oncology at Novotech, as she breaks down how the next generation of immuno-oncology innovation is transforming clinical development. In this episode Sarah shares practical takeaways sponsors can apply today, including:

  • How to move efficiently from signal-finding to registrational strategy
  • Designing for speed and quality across Europe, North America and APAC
  • Data, biometrics, and operations lessons informed by 800+ global oncology trial

Tune in to hear how Novotech partners with biotech and pharma clients to navigate the complexities of next-gen immuno-oncology trials, from concept to clinic.